Advocacy of policies, legislation and coverage of new pharmaceuticals in the orphan drug space.
2026 · 2nd Quarter (Apr 1 - June 30)
PHARVARIS, INC.
Filed by ARENTFOX SCHIFF LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 18, 2026
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- ARENTFOX SCHIFF LLP
- Client
- PHARVARIS, INC.
- Filing UUID
- b969c4f9-d11d-479e-b459-51806fb14b89
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.